Loading clinical trials...

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGPhase 2NCT05609578

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

Study CA239-0010 is an open-label, Phase 2 clinical trial evaluating the clinical efficacy of adagrasib in combination with pembrolizumab and chemotherapy in the first-line setting for patients with a...

Lead sponsor: Mirati Therapeutics Inc.•84 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

BMS Clinical Trials Contact Center www.BMSClinicalTrials.com

CONTACT

855-907-3286 [email protected]

First line of the email MUST contain the NCT# and Site #.

CONTACT

Related studies

RECRUITINGPhase 1/2

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

NCT05098132 · Advanced Solid Tumor, Non Small Cell Lung Cancer, and more

RECRUITINGPhase 1

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

NCT06625775 · Solid Tumor, Adult, Metastatic Breast Cancer, and more

RECRUITINGPhase 1

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

NCT06343402 · Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, and more

RECRUITINGPhase 2

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients

NCT07171606 · First-line Advanced NSCLC Patients

RECRUITINGPhase 2

Definitive Radiation for High-Risk Spine Metastases

NCT06165419 · Metastatic Cancer, Metastatic Lung Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 17, 2025Terms

Trial snapshot

StatusRECRUITING

PhasePHASE2

Enrollment90

Start dateNov 2022

Last updatedAug 17, 2025

Condition

Advanced NSCLC Metastatic Lung Cancer

Locations shown

Local Institution - Unk025

Anchorage, Alaska

Local Institution - 017-591

Glendale, Arizona

Local Institution - 017-821

Phoenix, Arizona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 17, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions